Back

The product of bilirubin and trigliseride is the most significant predictor of severe FIB-4 index of liver disease in cardiac patients

30 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Emerging biomarkers and molecular mechanisms in cardiovascular disease: from inflammation to remodelling Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Sera Celik

Medeniyet University, Istanbul (Turkiye)

6 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor S. Mckittrick (Castlebar, IE)
Abstract Slides Video
Presentation thumbnail
Mr S. Kumar (New Delhi, IN)
Abstract Slides Video
Presentation thumbnail
Miss M. Liu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Doctor A. Kamdar (Glasgow, GB)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Emerging biomarkers and molecular mechanisms in cardiovascular disease: from inflammation to remodelling

The Event

Event poster

ESC Congress 2025

30 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
An Elevated FIB-4 Score is associated with the severity of heart failure
thumbnail
Congress Presentation
Clinical utility of the FIB-4 index for predicting cardiovascular outcomes in patients with metabolic dysfunction-associated steatotic liver disease: a 10-year retrospective cohort study
thumbnail
Congress Presentation
Profiles of patients with cardiovascular risk factors and the severity of hepatic steatosis and fibrosis assessed by pulsed ultrasound

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources